Eli Lilly and Company - Cash and Equivalents

Eli Lilly and Company's Fiscal Year is From January To December - All Figures are in USD, Billions.

The item "Cash-and-Equivalents" stands at 9.79 Billion United States Dollars as of 09/30/2025, the highest value at least since 03/31/2011, the period currently displayed.

As of the end of Eli Lilly and Company's third quarter, the item "Cash and Equivalents" stands at 9.79 Billion USD. This represents an increase of 190.05 percent compared to it's value at the end of it's second quarter .


Regarding the One-Year-Change of the series, the current value constitutes an increase of 190.65 percent compared to the value the year prior.
The 1 year change in percent is 190.65.
The 3 year change in percent is 274.11.
The 5 year change in percent is 172.35.
The 10 year change in percent is 202.33.

The Serie's long term average value is 3.86 Billion United States Dollars. It's latest available value, on 09/30/2025, is 153.52 percent higher, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 09/30/2019, to it's latest available value, on 09/30/2025, is +526.16%.
The Serie's change in percent from it's maximum value, on 09/30/2025, to it's latest available value, on 09/30/2025, is 0.0%.